Navigation Links
Unilife to Present at the 2011 UBS Global Life Sciences Conference in New York City
Date:9/16/2011

YORK, Pa., Sept. 16, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that it will be presenting at the 2011 UBS Global Life Sciences Conference in New York City. Alan Shortall, Chief Executive Officer of Unilife, is scheduled to present at 1:00 p.m. EDT on Monday, September 19, 2011 (Tuesday, September 20 at 3:00 a.m. AEST).

The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of each event will also be available for those unable to listen live.

About Unilife CorporationUnilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S.-based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.  For more information on Unilife, please visit www.unilife.com

Forward-Looking Statements This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

Stuart Fine

Jeff CarterKCSA Strategic Communications

Carpe DM Inc

Unilife CorporationPhone + 1 212-682-6300

Phone + 1 908 469 1788

Phone + 61 2 8346 6500
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients
2. Unilife to Participate in Two Investor Conferences
3. Unilife COO to Again Purchase More Than $250,000 in Company Shares
4. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
5. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
6. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
7. Unilife Signs $10 Million Equipment Financing Agreement
8. Unilife Expands Management Team to Support Business Growth
9. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
10. Unilife Successfully Completes Industrialization of Unifill Syringe
11. Unilife Hosts White House Business Council Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) today announced ... Aug. 7, 2017. ... and will serve as president emeritus during a planned, 90-day ... multiple leadership roles since he joined Diplomat with the acquisition ... decisive, strategic leadership which continues to benefit our patients and ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait left ... she took with her a dream to make nursing education more relevant and prepare ... communication skills were integrated into healthcare provider education. , “The human element ...
(Date:8/17/2017)... ... August 17, 2017 , ... The line-up includes voices from all ... grow a dental practice in a competitive market environment where Corporate Dentistry is making ... just transform you and your practice.” says Daniel A. ‘Danny’ Bobrow, AIM Dental Marketing’s ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... distinguishes herself once more by being among Houston’s first plastic surgeons to offer ... quality plastic surgery care without disrupting busy schedules and maintaining the utmost discretion ...
(Date:8/17/2017)... ... 17, 2017 , ... Florida Hospital Zephyrhills showcased its newly ... The newly renovated ER was designed with patients in mind and offers: 24 ... to deliver patient results, improve efficiencies and reduce length of stay, two pirate-themed ...
(Date:8/17/2017)... ... , ... With the introduction of new devices, new features, and updates to ... smartwatch market. As of June 2017, nearly nine percent of U.S. consumers aged 18+ ... according to latest WEAR Report Industry Overview and Forecast from NPD’s Connected Intelligence, growth ...
Breaking Medicine News(10 mins):